Development of therapies that can promote regenerative, rather than reparative, healing hold the promise of improving patient recovery from tendon and ligament injuries by producing tissue that is morphologically and functionally equivalent to the native tissue. One therapeutic approach that has been a frequent topic of investigation in the preclinical literature is the use of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) to augment tendon and ligament repair. The chemotactic, mitogenic, and pro-angiogenic

properties of rhPDGF-BB have been shown to result in recruitment and proliferation of tenogenic cells and a commensurate Staurosporine boost in extracellular matrix deposition and organization, improving the morphological and biomechanical properties of healing tendons and ligaments. The outcomes of the preclinical studies reviewed here strongly suggest that rhPDGF-BB will provide a new therapeutic opportunity to improve the treatment of injured tendons and ligaments.”
“Orlistat, an antiobesity drug with well-documented efficacy in weight reduction and maintenance, has beneficial effects on metabolic variables. It reduces the incidence of Type 2 diabetes in patients with impaired glucose tolerance and decreases LDL-C levels to a greater

degree than expected from weight loss alone. Orlistat is a useful therapy in overweight and obese subjects with cardiovascular risk factors. The combination of orlistat with statins, fenofibrate check details and ezetimibe led to greater reductions of LDL-C levels compared with each monotherapy. The combination of orlistat with fenofibrate or ezetimibe also further decreased the concentration of atherogenic, small, dense LDL-C, as well as total plasma lipoprotein-associated phospholipase A2 activity, and improved several cardiovascular risk factors compared with monotherapy. However, studies investigating the

combination of orlistat with other hypolipidemic drugs only included a small number of subjects with hyperlipidemia or the metabolic syndrome.”
“In this work the magnetocaloric effect in ferrimagnetic rare-earth iron garnets R3Fe5O12 where R=Y and Dy was theoretically investigated considering a model Hamiltonian, which takes into account three coupled magnetic sublattices in the mean field approximation. In Dy3Fe5O12 P5091 the inverse magnetocaloric effect was predicted and associated with the compensation temperature. Our theoretical results for the adiabatic temperature change in both compounds are in good agreement with the experimental data.”
“Recently, dental stem and progenitor cells have been harvested from periodontal tissues such as dental pulp, periodontal ligament, follicle, and papilla. These cells have received extensive attention in the field of tissue engineering and regenerative medicine due to their accessibility and multilineage differentiation capacity.